Company profileoryzon.com ↗

Oryzon Genomics Sa

Oryzon Genomics is a clinical-stage biopharmaceutical company focused on epigenetics and personalized medicine for central nervous system disorders and oncology/hematology.

Biotechnology
Headquarters
Cornellà De Llobregat, SpainSource: RevenueBaseRetrieved October 13, 2026
Employee range
11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded
2000Source: RevenueBaseRetrieved October 13, 2026
Published list appearances
11 supported appearances ↗Source: RevenueBase lists
The company at a glance

What does Oryzon Genomics Sa do?

Oryzon is headquartered in Barcelona, Spain, with a team across Barcelona, Boston, and New Jersey. Its clinical portfolio is built around two LSD1 inhibitors.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

LSD1 inhibitor programs

Iadademstat, its oncology/hematology program, is being evaluated in multiple Phase I and II clinical trials.

Source: LinkedIn company description · Retrieved October 13, 2026

Neuropsychiatric clinical development

Vafidemstat is in clinical development across neuropsychiatric indications, including aggression in borderline personality disorder, negative symptoms of schizophrenia, and aggression in autism spectrum disorder, including genetically defined populations.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEWOryzon Genomics Sa listed #2 on Drug development analytics companies, September 27, 2026Open the published source list.
Oryzon Genomics Sa

#2 Drug development analytics companies

Snapshot: September 27, 2026

Download SVG
View live list ↗

Company information

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026, September 19, 2026, September 27, 2026 and October 8, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →